Response of blood glucose and GLP-1 to different food temperature in normal subject and patients with type 2 diabetes

被引:0
|
作者
Yun Hu
Peng Zhang
Bo Ding
Xin Cao
Yi Zhong
Kok-Onn Lee
Jian-Hua Ma
机构
[1] Wuxi People’s Hospital Affiliated to Nanjing Medical University,Department of Endocrinology
[2] Nanjing Medical University,Department of Endocrinology, Nanjing First Hospital
[3] National university hospital of Singapore,Department of Endocrinology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [42] Additive glucose-lowering effects of GLP-1 and metformin in type 2 diabetes.
    Zander, M
    Madsbad, S
    Holst, JJ
    DIABETOLOGIA, 2000, 43 : A185 - A185
  • [43] Effects of variations in duodenal glucose load on glycaemia, insulin and GLP-1 in type 2 diabetes
    Rayner, C. K.
    Ma, J.
    Pilichiewicz, A.
    Feinle-Bisset, C.
    Checklin, H. L.
    Wishart, J. M.
    Jones, K. L.
    Horowitz, M.
    DIABETOLOGIA, 2009, 52 : S105 - S106
  • [44] Biphasic and glucose dependent response to GLP-1 administered intravenously to normal rats
    Yakubu-Madus, FE
    James, B
    Kristina, B
    Judith, H
    Diana, S
    William, JT
    DIABETES, 1998, 47 : A294 - A294
  • [45] Effects of Dulaglutide, A GLP-1 Agonist, on Ambulatory Diurnal and Nocturnal Blood Pressure in Patients with Type 2 Diabetes
    Ferdinand, K. C.
    Calhoun, D. A.
    Lonn, E. M.
    White, W. B.
    Sager, P.
    Jiang, H.
    Threlkeld, R. J.
    JOURNAL OF CLINICAL HYPERTENSION, 2013, 15
  • [46] The Potentiating Effect of GLP-1 on Glucose-induced Glucagon Suppression in Healthy Individuals and in Patients with Type 1 and 2 Diabetes
    Bagger, Jonatan I.
    Lund, Asger
    Grondahl, Magnus
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    DIABETES, 2016, 65 : A487 - A487
  • [47] Effects of Sitagliptin and Metformin Treatment on GLP-1 Responses to Oral Glucose and on the Incretin Effect in Patients With Type 2 Diabetes
    Vardarli, Irfan
    Arndt, Elisabeth
    Deacon, Carolyn F.
    Holst, Jens J.
    Kothe, Lars D.
    Nauck, Michael A.
    DIABETES, 2012, 61 : A17 - A17
  • [48] Mechanism-based population modelling of the effects of vildagliptin on GLP-1, glucose and insulin in patients with type 2 diabetes
    Landersdorfer, Cornelia B.
    He, Yan-Ling
    Jusko, William J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (03) : 373 - 390
  • [49] GLP-1 receptor agonists in the management of Type 2 Diabetes
    Lambert, Lynn
    SA PHARMACEUTICAL JOURNAL, 2016, 83 (02) : 11 - 13
  • [50] Exenatide, a GLP-1 agonist in the treatment of Type 2 diabetes
    Sennik, Devesh
    Ahmed, Fahad
    Russell-Jones, David
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (01) : 15 - 26